Solara Active Pharma Sciences Limited (BOM:541540)
India
· Delayed Price · Currency is INR 521.15
-1.70 (-0.33%)
At close: Apr 21, 2025
BOM:541540 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2017 - 2019 |
| Net Income | - | -5,674 | -221.8 | -581.5 | 2,214 | 1,146 | Upgrade
|
| Depreciation & Amortization | - | 1,011 | 1,066 | 1,081 | 1,056 | 912.5 | Upgrade
|
| Other Amortization | - | 21.9 | 46.1 | 41.9 | 30.9 | 29.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 19.7 | 4.5 | 7.7 | -20 | 3.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 25.3 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 6 | 0.5 | -13.1 | 51.4 | 56 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 109.9 | 56.6 | 88.2 | - | 7 | Upgrade
|
| Other Operating Activities | - | 3,662 | 603.4 | 93.1 | 281 | 432.1 | Upgrade
|
| Change in Accounts Receivable | - | 1,782 | -528 | -145.5 | -2,574 | 678 | Upgrade
|
| Change in Inventory | - | 130.8 | 173.2 | -2,806 | -152.4 | -657.9 | Upgrade
|
| Change in Accounts Payable | - | 73 | 389 | -238.8 | 966.7 | -280.5 | Upgrade
|
| Change in Other Net Operating Assets | - | -79.2 | -26.8 | 52.2 | -299 | 95.9 | Upgrade
|
| Operating Cash Flow | - | 1,089 | 1,563 | -2,420 | 1,555 | 2,422 | Upgrade
|
| Operating Cash Flow Growth | - | -30.32% | - | - | -35.80% | 45.58% | Upgrade
|
| Capital Expenditures | - | -410.6 | -1,113 | -2,086 | -1,745 | -2,689 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 10.4 | 13 | 1.3 | 29.7 | 13 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -551 | Upgrade
|
| Investment in Securities | - | - | -12.8 | - | -1 | 0.9 | Upgrade
|
| Other Investing Activities | - | 41.6 | 125 | -343.6 | 653.1 | -362.3 | Upgrade
|
| Investing Cash Flow | - | -35.1 | -811.4 | -2,429 | -1,063 | -3,588 | Upgrade
|
| Short-Term Debt Issued | - | 1,115 | 394.4 | 2,487 | 68.2 | 1,301 | Upgrade
|
| Long-Term Debt Issued | - | 49 | 683 | 2,624 | 1,558 | 1,344 | Upgrade
|
| Total Debt Issued | - | 1,164 | 1,077 | 5,111 | 1,626 | 2,644 | Upgrade
|
| Long-Term Debt Repaid | - | -1,194 | -1,331 | -962.2 | -2,654 | -1,026 | Upgrade
|
| Total Debt Repaid | - | -1,194 | -1,331 | -962.2 | -2,654 | -1,026 | Upgrade
|
| Net Debt Issued (Repaid) | - | -30.2 | -253.1 | 4,149 | -1,028 | 1,618 | Upgrade
|
| Issuance of Common Stock | - | - | - | 29 | 2,982 | 297.6 | Upgrade
|
| Common Dividends Paid | - | - | - | -107.8 | -197.3 | -156.2 | Upgrade
|
| Other Financing Activities | - | -1,026 | -874.5 | -734 | -831.9 | -789.7 | Upgrade
|
| Financing Cash Flow | - | -1,057 | -1,128 | 3,336 | 924.9 | 969.8 | Upgrade
|
| Net Cash Flow | - | -2.9 | -376.5 | -1,513 | 1,417 | -196.8 | Upgrade
|
| Free Cash Flow | - | 678.1 | 449.4 | -4,507 | -190.2 | -267.2 | Upgrade
|
| Free Cash Flow Growth | - | 50.89% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | 5.26% | 3.11% | -35.53% | -1.18% | -2.02% | Upgrade
|
| Free Cash Flow Per Share | - | 18.84 | 12.48 | -125.38 | -5.54 | -9.98 | Upgrade
|
| Cash Interest Paid | - | - | - | 734 | 831.9 | 789.7 | Upgrade
|
| Cash Income Tax Paid | - | -9 | -135.4 | 181 | 333.6 | 243.4 | Upgrade
|
| Levered Free Cash Flow | - | 3,506 | -82.46 | -5,069 | -957.98 | -2,405 | Upgrade
|
| Unlevered Free Cash Flow | - | 4,132 | 460.04 | -4,616 | -455.85 | -1,935 | Upgrade
|
| Change in Net Working Capital | - | -4,738 | -288.3 | 3,478 | 1,628 | 1,326 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.